Refined cancer models are required if researchers are to assess the burgeoning number of potential targets for cancer therapeutics in a clinically relevant context that allows a fast turnaround. Here we use tumor-associated genetic pathways to transform primary human epithelial cells from the epidermis, oropharynx, esophagus and cervix into genetically defined tumors in a human three-dimensional (3D) tissue environment that incorporates cell-populated stroma and intact basement membrane. These engineered organotypic tissues recapitulated natural features of tumor progression, including epithelial invasion through basement membrane, a complex process that is necessary for biological malignancy in 90% of human cancers. Invasion was rapid and was potentiated by stromal cells. Oncogenic signals in 3D tissue, but not 2D culture, resembled gene expression profiles from spontaneous human cancers. We screened 3D organotypic neoplasia with well-characterized signaling pathway inhibitors to distill a clinically faithful cancer gene signature. Multitissue 3D human tissue cancer models may provide an efficient and relevant complement to current approaches to characterizing cancer progression.
Refined cancer models are required if researchers are to assess the burgeoning number of potential targets for cancer therapeutics in a clinically relevant context that allows a fast turnaround. Here we use tumor-associated genetic pathways to transform primary human epithelial cells from the epidermis, oropharynx, esophagus and cervix into genetically defined tumors in a human three-dimensional (3D) tissue environment that incorporates cell-populated stroma and intact basement membrane. These engineered organotypic tissues recapitulated natural features of tumor progression, including epithelial invasion through basement membrane, a complex process that is necessary for biological malignancy in 90% of human cancers. Invasion was rapid and was potentiated by stromal cells. Oncogenic signals in 3D tissue, but not 2D culture, resembled gene expression profiles from spontaneous human cancers. We screened 3D organotypic neoplasia with well-characterized signaling pathway inhibitors to distill a clinically faithful cancer gene signature. Multitissue 3D human tissue cancer models may provide an efficient and relevant complement to current approaches to characterizing cancer progression.
High-throughput genomics have accelerated the identification of genetic alterations in human cancers 1, 2 . The high number of mutations in individual tumors and the substantial heterogeneity between tumors hinders the evaluation of specific genetic changes 3 . This difficulty arises partly from technical limitations that are intrinsic to the conventional mouse-and cell line-based models that are commonly used for functional analysis of specific genetic alterations. Genetically engineered mice are costly, time-consuming, not amenable to high-throughput combinatorial genetic or pharmacological screens and can show considerable differences from humans with regard to requirements for oncogenic transformation 4, 5 . Models based on tumor cell lines often lack key malignancy features and suffer from accumulated mutations that might confound functional studies. The capacity to directly transform primary human cells into genetically defined malignancies provides a model in which to assess the effects of tumor-associated genes, as well as a benchmark positive control for tumorigenesis assays that are free of secondary genetic changes. Previous efforts to convert normal primary human cells into neoplasia required different combinations of human and viral oncogenes depending on cell type [6] [7] [8] [9] [10] , and a minimal set of oncogenic changes that can transform multiple human primary cell types in parallel has not been established.
Here we present a rapid method for malignant conversion of normal primary human epidermal, cervical, esophageal and oropharyngeal epithelial cells, representing each of the stratified squamous epithelia that are associated with human cancer. We transformed these tissue types into invasive neoplasias by introducing a physiologically relevant pair of genetic elements that encoded active human Ras and cyclin-dependent kinase-4 (Cdk4). These elements mediate the activation of the Ras pathway and bypass of retinoblastoma (Rb)-mediated G1 cell cycle restraints, both of which are commonly seen in spontaneous human epithelial cancers. We used these transformed epithelial cells to develop 3D human tissue models in which the key steps in cancer progression were recapitulated, including invasion through intact basement membrane into supporting stroma. As nearly 90% of human malignancies are epithelial in origin 11 , it is essential that we identify the elements that drive invasion from the in situ environment, because it is only within the supporting stroma that cancer cells gain access to the vascular and lymphatic systems that allow them to spread systemically. Stromal cells and the extracellular matrix have key roles in regulating the tumor microenvironment and can both promote and antagonize tumor progression [12] [13] [14] [15] . We therefore established in vitro organotypic epithelial cancer models that comprised genetically defined neoplastic epithelium, as well as intact basement membrane, supported by cell-populated living stroma and native extracellular matrix. In this 3D context, engineered neoplastic epithelial cells progressed from the in situ environment and invaded through the basement membrane into the stroma within 1 week. These model tissues allowed us to achieve rapid assessment of potential pharmacologic inhibitors of invasion and highlighted the Ras effector pathway and gene expression signature associated with neoplastic invasion. Organotypic models of human neoplasia might facilitate the translation of the cancer genome into strategies for cancer therapy and prevention.
RESULTS
We induced the expression of oncogenic Ras and the bypass of Rb, in the form of enforced Cdk4 expression, in primary human epithelial cells from the epidermis, cervix, esophagus and oropharynx by using high-efficiency retroviral transfer without drug selection 16 . Twenty-four hours after transduction, we injected the cells into the subcutaneous space of immunodeficient mice. Within 30 d, tumors were present at each injection site (Supplementary Table 1 ). The tumors comprised epithelial neoplasias with squamous morphology, reflecting the typical histological features of spontaneous carcinomas that arise at these sites (Supplementary Fig. 1 ). Thus, oncogenic Ras and bypass of Rb efficiently induce tumorigenic conversion of primary epithelial cells from multiple human stratified epithelia.
Establishment of invasive 3D organotypic tissues
Although subcutaneous tumorigenesis is a standard assay for oncogenic transformation, it lacks features of native cancer progression, including the key step of basement membrane invasion. To model this, we regenerated the four types of human stratified epithelia on intact basement membrane with cell-populated human stroma in organotypic tissue. The structural tissue framework for the regenerated tissues was an acellular derivative of cutaneous dermis, a stratified epithelial stroma containing extracellular matrix proteins and secreted basement membrane elements. Tissue generated from normal cells of each cell type attached to and respected the basement membrane ( Figs. 1 and 2) . Epidermal organotypic tissue showed normal stratification and differentiation (Fig. 1c) , including a fully formed basement membrane with normal ultrastructural elements ( Fig. 1d-f ). By contrast, epithelial tissues that expressed oncogenic Ras and Cdk4 showed disrupted polarity and epithelial cell invasion through the basement membrane, both of which are hallmarks of early invasive neoplasia (Fig. 2) . Neoplastic changes occurred within 6 d, indicating that multiple stratified human epithelia can be rapidly converted to invasive neoplasms in organotypic tissue.
To mimic oncogene activation induced by somatic mutation in normal tissue in situ, we also co-expressed a 4-hydroxytamoxifen (4OHT)-inducible estrogen receptor-Ras fusion protein 17 with Cdk4 in epidermal keratinocytes. We allowed the establishment of normal differentiated multilayer tissue and then activated Ras by treating the cells with 4OHT. The activation of the inducible oncogene also led to invasion (Supplementary Fig. 2 ), similar to that seen in cells that expressed constitutively active Ras. Stromal invasion was associated with focal gaps in the previously continuous basement membrane (Fig. 3) . Stromal fibroblasts secrete proteins that have a role in the structural integrity of the basement membrane 18 , but they also secrete tumor-enabling growth factors and chemotactic agents, raising the question of whether they would impair or enable invasiveness. Although they were not required for invasion, stromal dermal fibroblasts enhanced invasion by more than 400% (Fig. 3e-g ). To investigate whether fibroblasts from other stratified epithelia would have similar effects to those from skin, we tested cervical stromal fibroblasts for their capacity to enhance cervical epithelial invasion. These fibroblasts had a similar invasion-potentiating effect ( Supplementary Fig. 3 ).
Organotypic tissue models of human neoplasia that contain primary human cells and an intact basement membrane represent an alternative to conventional in vitro invasion assays. The latter assays measure migration through Matrigel-coated perforated synthetic filters in Boyden chamber-based transwells as an invasion surrogate. Such assays allow some migration by normal cells; by contrast, normal cells in organotypic tissue never invaded through the intact basement membrane ( Figs. 1 and 2) . Also, consistent with substantial differences between these approaches, the human stratified epithelial tumor line A431, which is highly invasive in Boyden chamber assays 19 , could not invade through intact basement membrane ( Supplementary  Fig. 4) . The inclusion of an intact basement membrane and stroma in organotypic models of neoplasia provides an alternative approach for studying the complex process of epithelial tumor invasion that might complement traditional synthetic filterbased assays. Three-dimensional organotypic models of human neoplasia may support screens for cancer targets. We tested 20 inhibitors (Supplementary Table 2 ) for their capacity to alter organotypic epidermal neoplasia. The use of many of these research agents in vivo is hindered by an inability to deliver them efficiently and by systemic toxicity. In this initial screen, three inhibitors impeded invasive neoplasia. Inhibition of the Ras-Raf-mitogen-activated protein kinase (MAPK) cascade at the level of mitogen-activated protein kinase kinase (Mek) and extracellular signal-regulated kinase (Erk) with U0126 completely blocked invasion at concentrations that had no apparent adverse effects on normal tissue, whereas blockade of another Ras effector, phosphatidylinositol 3-kinase (PI3K), had no detectable effect on invasion (Fig. 4a) , suggesting that the Ras-Raf-MAPK cascade is a primary pathway that drives this process. Although U0126-treated neoplastic cells did not invade, they continued to proliferate (Supplementary Fig. 5 ). The broad-spectrum protease inhibitor GM6001 and the Jun N-terminal kinase (JNK) inhibitor SP600125 also both diminished invasion depth, but did permit some epithelial cells to penetrate the basement membrane into the stroma (Supplementary Table 2 ). Organotypic neoplasia thus offers a means for screening inhibitors of neoplastic invasion in a 3D human tissue context.
Correlation between organotypic tissues and human tumors
To begin to characterize stratified epithelial organotypic neoplasia models, we used Affymetrix oligonucleotide microarrays to obtain gene expression profiles from invasive organotypic epidermis and cervix tissues that expressed constitutively active H-Ras and Cdk4 with and without U0126-mediated blockade of Mek and Erk. In both epidermis and cervix, U0126 had a dominant effect, reverting most of the gene changes introduced by the oncogenic stimulus ( Fig. 4b and Supplementary Fig. 6 ). In organotypic epidermal neoplasia, 483 genes were differentially expressed compared with non-neoplastic cells (Supplementary Table 3) , and 74% (356) of these genes were reverted to normal expression by U0126 (Supplementary Table 3) . In organotypic cervical neoplasia, 366 genes were differentially expressed (Supplementary Table 4) , and 71% (259) of these genes were reverted by U0126. There was a highly significant overlap (P = 1.2 × 10 −79 , n = 113) between the differentially expressed genes from the two tissue types, indicating that the tissues respond to oncogenic Ras with both common and tissue-specific transcriptional responses. The reverted genes were enriched in gene ontology terms associated with cancer, including angiogenesis, metabolism, cell motility, differentiation, wounding and cell adhesion (Supplementary Table 5 ). The relative expression of these genes in organotypic epidermal neoplasia correlated with a series of spontaneous head and neck squamous cell carcinomas (SCCs) 20 (Pearson coefficient 0.41, P = 4.0 × 10 −16 ; Fig. 4c ), indicating that organotypic neoplasia engages gene regulatory changes similar to those seen in naturally occurring cancers.
To determine the degree to which organotypic neoplasia reflects transcriptional changes in spontaneous human SCCs, and to compare the correlation with other available models of SCC, we generated 22 separate gene lists consisting of genes that were differentially expressed in each of 22 previously reported 21 spontaneous SCCs compared to matched adjacent normal tissue. The relative expression of each gene in these 22 gene sets was then examined in multiple SCC models, including 3D organotypic neoplasia; 2D culture of the epithelial cells that were used to generate organotypic neoplasia; an in vivo Ras-driven SCC model 22 in which regenerated normal and neoplastic human skin was grafted on immunodeficient mice; 2D culture of a series of ten human SCC cell lines 23 ; and a second independent set of human SCC tumors that were matched to adjacent normal control tissue 20 . We examined the expression of each gene in each of the models and compared this with its expression in the corresponding control samples (tissue or primary cell culture) for each model system. We calculated Pearson coefficients between each of the 22 gene sets and each of the individual samples from the five model systems (Fig. 4d) . As expected, the highest correlation was between the two sets of spontaneous human clinical specimens (median Pearson coefficient = 0.45, P = 1.3 × 10 −12 ), indicating that the most faithful replicate of a given spontaneous clinical SCC is another human SCC. The 3D organotypic model was also highly correlated (Pearson coefficient = 0.34, P = 1.1 × 10 −6 ) to a degree nearly identical to the in vivo grafting model, indicating that the transcriptional response to oncogenic signaling in organotypic neoplasia resembles that in the orthotopic in vivo model, as well as in spontaneous clinical SCCs.
Unlike 3D organotypic tissue expressing Ras and Cdk4, 2D culture of the same epithelial cells showed a Pearson coefficient of 0.0 with natural SCC tumors, indicating that there were profound differences between the 2D and 3D environments. Consistent with this, established SCC cell lines grown in 2D culture 23 gene expression patterns of human SCC tumors in vivo. To verify these results, we used the same analytic approach to quantify the correlation between gene expression in a second set of natural human SCCs 20 and the multiple SCC models. These results were nearly identical to those obtained with the first SCC tumor set ( Supplementary  Fig. 7b) . Together, these findings indicated that genes that are altered in spontaneous tumors were similarly regulated in the 3D organotypic model of neoplasia but not in 2D cultured cells. In a faithful model, genes that were substantially altered in the model system should also be similarly regulated in the spontaneous tumors. This was true for organotypic neoplasia. The relative expression of genes that were altered in the models correlated markedly with their expression in both sets of spontaneous tumors (Supplementary Fig. 7c,d) ; by contrast, the 2D cultures showed no correlation. Thus, 3D organotypic neoplasia might offer distinct advantages over 2D models with regard to physiological relevance and may represent a useful complement to conventional cancer models.
DISCUSSION
We have described an approach for producing organotypic models of human neoplasia using primary epithelial cells from multiple stratified epithelial tissues. To our knowledge, this is the first generation of genetically defined tumors from primary human esophageal, oropharyngeal and cervical epithelial cells. Organotypic neoplasia developed within 1 week and could be induced by regulated activation of Ras in situ. Organotypic neoplasia showed enhanced invasion in the presence of stromal cells, as well as the capacity to serve as a platform for assessing inhibitors of invasion. Finally, global gene expression in organotypic neoplasia was significantly correlated with gene expression in spontaneous human cancer, suggesting that it represents a useful complement to current cancer models.
We converted primary human epithelial cells into neoplastic cells using oncogenic Ras-and Cdk4-mediated bypass of Rb cell cycle restraints. This combination is relevant to spontaneous human cancer. Large-scale human tumor sequencing efforts, including the Cancer Genome Atlas and the Catalog of Somatic Mutations in Cancer, identified the Ras and Rb pathways as among the most commonly mutated pathways in human cancers, and Ras, one of the most frequently mutated oncogenes, is frequently activated in stratified epithelial cancers 24, 25 . Cdk4 is activated in epithelial cancers by gene amplification and activating point mutations, among other causes. The use of these genetic elements, which are found in spontaneous human tumors, represents an important line of experimentation that is likely to increase the relevance of tumor models to spontaneous malignancy. This oncogenic gene set proved to be remarkably efficient, rapidly transforming all four cell types into populations that formed invasive tumors without the requirement for drug selection, in vitro passage, viral oncoproteins or clonal selection. This allowed us to use primary human cells as the starting substrate for interrogation, as opposed to cell lines that are adapted for long-term culture. Ras and Cdk4 may thus be useful as a positive control benchmark in organotypic neoplasia studies designed to characterize the function of other genetic changes that have been identified in human tumor samples.
Although stromal fibroblasts could not drive invasive behavior in the absence of epithelial-intrinsic oncogenic drivers, they clearly augmented invasion. In this context, their function might be analogous to the enabling supportive function performed by non-oncogene addicted genes 26 in the tumor cells themselves. Systematically characterization of stromal factors that enable invasion may highlight potential therapeutic targets for a range of epithelial tumors. The idea of directing therapeutics toward the stroma directly, rather than the cancer cells, is particularly attractive, as stromal cells represent a more genetically stable target that is less likely to develop resistance.
We noted marked differences between the ability of neoplastic cells to invade through basement membrane and to migrate through Matrigel. Invasion through intact basement membrane requires that cells move through a dense, highly ordered structure, which may represent a more formidable obstacle than commonly used semisolid gels. In that regard, the invasion assay described here (Supplementary Fig. 8 ) might recapitulate the process of epithelial tumor cell invasion in vivo more accurately than Boyden chamber migration assays. The determination of the merit of one method over another may require the identification and functional validation of invasion inhibitors and cancer therapeutics that prove to be useful both in preclinical models and in clinical use. However, Matrigel-based 3D culture systems have proven to be useful for distinguishing normal from malignant mammary epithelial cells on the basis of their ability to form organized spheroids and deposit the basement membrane component collagen IV 27 .
Organotypic tissue proved to be a useful platform for drug assessment, and allowed us to implicate the Ras downstream Raf-Mek-Erk MAPK cascade as being required for the invasive phenotype. Whereas the Mek inhibitor U0126 abrogated invasion and reversed most of the associated gene changes, the Raf inhibitor did not. Although the mechanisms that underlie this difference are not clear, it probably reflects functional redundancy at the level of Raf. There are only two isoforms of Mek, both of which are inhibited by U0126. However, Raf has multiple isoforms including a-Raf, b-Raf and c-Raf. The inhibitor that we used is targeted to c-Raf, and compensation by the other isoforms might be sufficient to transmit the Ras signal and drive invasion. Other possibilities exist, reflecting the complexity of Raf action, including the finding that Raf inhibition can paradoxically stimulate MAPK activity in the context of active Ras 28 .
To establish the degree to which the organotypic neoplasia reflects the biology of spontaneous tumors, we developed an analytical method of quantitative transcriptome analysis based on the Pearson correlation between transcriptional responses to oncogenic stimuli in the model tissue and spontaneous human tumors. This approach quantified the baseline degree of correlation and heterogeneity between individual spontaneous human SCC tumors, and showed a greater relative correlation between the 3D organotypic and in vivo models and spontaneous cancers than between 2D cultured cells and spontaneous cancers. This may be a key point to consider when designing experiments based on cancer cell lines grown in vitro.
Although it would also be of interest to compare gene expression profiles between organotyic tissues and orthotopic in vivo grafts from tissue types other than epidermis, this is currently not possible owing to the lack of a suitable normal control tissue for the analysis. In the case of epidermis, tissue grafts consisting of normal control keratinocytes are also grafted onto mice and used as a baseline for comparison with the invasive Ras-expressing grafts. In this regard, the epidermis presents a unique opportunity to conduct such comparison analyses. There are currently no available methods, to our knowledge, that would allow us to regenerate normal human esophagus, cervix or oral mucosa in the orthotopic site on a mouse to make an 'in vivo model' analogous to that which we have developed for skin. It is because of that technical limitation that we used the established standard of subcutaneous injection for these other tissues. Although tumors form from all four Ras and Cdk4-expressing cell types, the control primary cells do not form tumors. Therefore, although we could obtain mRNA from the subcutaneous tumors, there was no corresponding in vivo tissue to use as an appropriate baseline for comparison for expression profiling studies, and the more in-depth profiling studies have thus focused on skin. Organotypic neoplasia therefore complements both traditional subcutaneous tumor formation assays and transgenic mouse studies by providing a standard experimental platform that is relatively inexpensive, rapid and based on primary human epithelial cells on intact basement membrane within 3D tissue.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
Note: Supplementary information is available on the Nature Medicine website.
